Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

TVGN vs BNTX

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
TVGN
Tevogen Bio Holdings Inc.

Biotechnology

HealthcareNASDAQ • US
Market Cap$1.48B
5Y Perf.-98.5%
BNTX
BioNTech SE

Biotechnology

HealthcareNASDAQ • DE
Market Cap$23.80B
5Y Perf.-45.3%

TVGN vs BNTX — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
TVGN logoTVGN
BNTX logoBNTX
IndustryBiotechnologyBiotechnology
Market Cap$1.48B$23.80B
Revenue (TTM)$0.00$2.86B
Net Income (TTM)$-31M$-1.13B
Gross Margin77.7%
Operating Margin-45.9%
Total Debt$3M$267M
Cash & Equiv.$1M$7.67B

TVGN vs BNTXLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

TVGN
BNTX
StockJan 22May 26Return
Tevogen Bio Holding… (TVGN)1001.5-98.5%
BioNTech SE (BNTX)10054.7-45.3%

Price return only. Dividends and distributions are not included.

Quick Verdict: TVGN vs BNTX

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: BNTX leads in 4 of 6 categories, making it the strongest pick for growth and revenue expansion and capital preservation and lower volatility. Tevogen Bio Holdings Inc. is the stronger pick specifically for profitability and margin quality. As sector peers, any of these can serve as alternatives in the same allocation.
TVGN
Tevogen Bio Holdings Inc.
The Growth Play

TVGN is the clearest fit if your priority is growth exposure.

  • EPS growth 47.6%
  • -5.3% margin vs BNTX's -39.6%
Best for: growth exposure
BNTX
BioNTech SE
The Income Pick

BNTX carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.

  • Dividend streak 1 yrs, beta 1.05
  • 5.8% 10Y total return vs TVGN's -98.5%
  • Lower volatility, beta 1.05, Low D/E 1.4%, current ratio 7.54x
Best for: income & stability and long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthBNTX logoBNTX0.2% revenue growth vs TVGN's -6.7%
Quality / MarginsTVGN logoTVGN-5.3% margin vs BNTX's -39.6%
Stability / SafetyBNTX logoBNTXBeta 1.05 vs TVGN's 1.95
DividendsTieNeither stock pays a meaningful dividend
Momentum (1Y)BNTX logoBNTX-0.7% vs TVGN's -86.3%
Efficiency (ROA)BNTX logoBNTX-5.3% ROA vs TVGN's -6.9%

TVGN vs BNTX — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

TVGNTevogen Bio Holdings Inc.

Segment breakdown not available.

BNTXBioNTech SE
FY 2025
Other Sales
100.0%$262M

TVGN vs BNTX — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLBNTXLAGGINGTVGN

Income & Cash Flow (Last 12 Months)

TVGN leads this category, winning 1 of 1 comparable metric.

BNTX and TVGN operate at a comparable scale, with $2.9B and $0 in trailing revenue.

MetricTVGN logoTVGNTevogen Bio Holdi…BNTX logoBNTXBioNTech SE
RevenueTrailing 12 months$0$2.9B
EBITDAEarnings before interest/tax-$30M-$931M
Net IncomeAfter-tax profit-$31M-$1.1B
Free Cash FlowCash after capex-$13M$277M
Gross MarginGross profit ÷ Revenue+77.7%
Operating MarginEBIT ÷ Revenue-45.9%
Net MarginNet income ÷ Revenue-39.6%
FCF MarginFCF ÷ Revenue+9.7%
Rev. Growth (YoY)Latest quarter vs prior year-24.5%
EPS Growth (YoY)Latest quarter vs prior year+13.5%-2.1%
TVGN leads this category, winning 1 of 1 comparable metric.

Valuation Metrics

TVGN leads this category, winning 1 of 1 comparable metric.
MetricTVGN logoTVGNTevogen Bio Holdi…BNTX logoBNTXBioNTech SE
Market CapShares × price$1.5B$23.8B
Enterprise ValueMkt cap + debt − cash$1.5B$15.1B
Trailing P/EPrice ÷ TTM EPS-79.91x-17.79x
Forward P/EPrice ÷ next-FY EPS est.
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple
Price / SalesMarket cap ÷ Revenue7.36x
Price / BookPrice ÷ Book value/share1.01x
Price / FCFMarket cap ÷ FCF75.18x
TVGN leads this category, winning 1 of 1 comparable metric.

Profitability & Efficiency

BNTX leads this category, winning 3 of 4 comparable metrics.
MetricTVGN logoTVGNTevogen Bio Holdi…BNTX logoBNTXBioNTech SE
ROE (TTM)Return on equity-6.0%
ROA (TTM)Return on assets-6.9%-5.3%
ROICReturn on invested capital-4.3%
ROCEReturn on capital employed-3.1%
Piotroski ScoreFundamental quality 0–944
Debt / EquityFinancial leverage0.01x
Net DebtTotal debt minus cash$2M-$7.4B
Cash & Equiv.Liquid assets$1M$7.7B
Total DebtShort + long-term debt$3M$267M
Interest CoverageEBIT ÷ Interest expense-219.56x-62.15x
BNTX leads this category, winning 3 of 4 comparable metrics.

Total Returns (Dividends Reinvested)

BNTX leads this category, winning 6 of 6 comparable metrics.

A $10,000 investment in BNTX five years ago would be worth $4,756 today (with dividends reinvested), compared to $151 for TVGN. Over the past 12 months, BNTX leads with a -0.7% total return vs TVGN's -86.3%. The 3-year compound annual growth rate (CAGR) favors BNTX at -4.5% vs TVGN's -76.0% — a key indicator of consistent wealth creation.

MetricTVGN logoTVGNTevogen Bio Holdi…BNTX logoBNTXBioNTech SE
YTD ReturnYear-to-date-58.9%-2.7%
1-Year ReturnPast 12 months-86.3%-0.7%
3-Year ReturnCumulative with dividends-98.6%-12.9%
5-Year ReturnCumulative with dividends-98.5%-52.4%
10-Year ReturnCumulative with dividends-98.5%+575.8%
CAGR (3Y)Annualised 3-year return-76.0%-4.5%
BNTX leads this category, winning 6 of 6 comparable metrics.

Risk & Volatility

BNTX leads this category, winning 2 of 2 comparable metrics.

BNTX is the less volatile stock with a 1.05 beta — it tends to amplify market swings less than TVGN's 1.95 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. BNTX currently trades 75.9% from its 52-week high vs TVGN's 9.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricTVGN logoTVGNTevogen Bio Holdi…BNTX logoBNTXBioNTech SE
Beta (5Y)Sensitivity to S&P 5001.95x1.05x
52-Week HighHighest price in past year$75.50$124.00
52-Week LowLowest price in past year$0.35$79.52
% of 52W HighCurrent price vs 52-week peak+9.9%+75.9%
RSI (14)Momentum oscillator 0–10055.540.1
Avg Volume (50D)Average daily shares traded34K1.2M
BNTX leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

Wall Street rates TVGN as "Hold" and BNTX as "Buy".

MetricTVGN logoTVGNTevogen Bio Holdi…BNTX logoBNTXBioNTech SE
Analyst RatingConsensus buy/hold/sellHoldBuy
Price TargetConsensus 12-month target$139.44
# AnalystsCovering analysts124
Dividend YieldAnnual dividend ÷ price
Dividend StreakConsecutive years of raises1
Dividend / ShareAnnual DPS
Buyback YieldShare repurchases ÷ mkt cap0.0%0.0%
Insufficient data to determine a leader in this category.
Key Takeaway

BNTX leads in 3 of 6 categories (Profitability & Efficiency, Total Returns). TVGN leads in 2 (Income & Cash Flow, Valuation Metrics).

Best OverallBioNTech SE (BNTX)Leads 3 of 6 categories
Loading custom metrics...

TVGN vs BNTX: Frequently Asked Questions

7 questions · data-driven answers · updated daily

01

Is TVGN or BNTX a better buy right now?

Analysts rate BioNTech SE (BNTX) a "Buy" — based on 24 analyst ratings — the highest consensus in this comparison.

The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which is the better long-term investment — TVGN or BNTX?

Over the past 5 years, BioNTech SE (BNTX) delivered a total return of -52.

4%, compared to -98. 5% for Tevogen Bio Holdings Inc. (TVGN). Over 10 years, the gap is even starker: BNTX returned +575. 8% versus TVGN's -98. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

03

Which is safer — TVGN or BNTX?

By beta (market sensitivity over 5 years), BioNTech SE (BNTX) is the lower-risk stock at 1.

05β versus Tevogen Bio Holdings Inc. 's 1. 95β — meaning TVGN is approximately 85% more volatile than BNTX relative to the S&P 500.

04

Which has better profit margins — TVGN or BNTX?

Tevogen Bio Holdings Inc.

(TVGN) is the more profitable company, earning 0. 0% net margin versus -39. 6% for BioNTech SE — meaning it keeps 0. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: TVGN leads at 0. 0% versus -22. 6% for BNTX. At the gross margin level — before operating expenses — BNTX leads at 77. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

05

Which pays a better dividend — TVGN or BNTX?

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

06

Is TVGN or BNTX better for a retirement portfolio?

For long-horizon retirement investors, BioNTech SE (BNTX) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1.

05), +575. 8% 10Y return). Tevogen Bio Holdings Inc. (TVGN) carries a higher beta of 1. 95 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (BNTX: +575. 8%, TVGN: -98. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

07

What are the main differences between TVGN and BNTX?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

TVGN

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
Run This Screen
Stocks Like

BNTX

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Gross Margin > 46%
Run This Screen

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.